Terms ending in 2029
Every in-force patent on CVRX, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,848,812 | Elective Service Indicator Based on Pulse Count for Implantable Device In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,401,652 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,600,511 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,700,162 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,948,874 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,744,586 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · Medium confidence | CVRX, Inc. | In force | Medium confidence | |
| US 8,116,873 | Measurement of Patient Physiological Parameters In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,321,024 | Devices and Methods for Treatment of Heart Failure and Associated Conditions In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,249,705 | Devices, Systems, and Methods for Improving Left Ventricular Structure and Function Using Baroreflex Activation Therapy In force · High confidence | CVRX, Inc. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.